fashion -WSS

fashion

author：Wikipedia 2025-09-27 13:02:28 - browse：64878

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

WSS

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Can medical device makers keep up in the race to treat obesity?

The UK government moves asylum

Inside the rise of 'mukbang' eating videos

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

At least 12 people were injured in a blast at a port in northwest Turkey

knowledge

fashion

focus

Hepatitis C has a cure — but many Americans still lack access to it

Timeline: Key moments in fight for gay rights

BioMarin wins approval for gene therapy to treat hemophilia A

Can medical device makers keep up in the race to treat obesity?

The high cost of giving birth even with insurance

Why workplace violence is so common in health care

How one medical school became remarkably diverse

Mom launches Girl Scout troop for LGBTQ youth in Texas

Duchenne breakthrough therapy leaves behind pioneering families

Mom launches Girl Scout troop for LGBTQ youth in Texas

focus

In medicine, common shorthands can shortchange care

Mom launches Girl Scout troop for LGBTQ youth in Texas

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Inside the rise of 'mukbang' eating videos

Eli Lilly’s Mounjaro succeeds in second weight

focus

hotspot

hotspot

hotspot